|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 38/21 | (2006.01) |
| A61K 38/37 | (2006.01) | ||
| A61K 39/00 | (2006.01) | ||
| A61K 47/68 | (2017.01) | ||
| C12Q 1/68 | (2018.01) | ||
| C07K 14/755 | (2006.01) | ||
| C12Q 1/6883 | (2018.01) | ||
| A61P 37/06 | (2006.01) |
| (11) | Patento numeris | 3453402 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18183272.6 |
| Europos patento paraiškos padavimo data | 2013-01-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2019-03-13 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2021-07-21 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 201261586103 P | 2012-01-12 | US | |
| 201261668961 P | 2012-07-06 | US |
| (72) |
JIANG, Haiyan , US
LIU, Tongyao , US
KRISHNAMOORTHY, Sriram , US
JOSEPHSON, Neil , US
GLENN, Pierce , US
|
| (73) |
Bioverativ Therapeutics Inc. ,
225 Second Avenue, Waltham MA 02451,
US
Puget Sound Blood Center , 921 Terry Avenue, Seattle, Washington 98104-1256, US |
| (54) | REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY |
| REDUCING IMMUNOGENICITY AGAINST FACTOR VIII IN INDIVIDUALS UNDERGOING FACTOR VIII THERAPY |